Cells constantly recycle proteins and other cellular components. But how do they ensure that the right cargo ends up in the ...

Emmecell, a clinical-stage biotechnology company developing magnetic cell delivery technologies for ophthalmic diseases, announced the successful closing of a strategic financing round. The financing ...

Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from ...

The schematic illustrates the structural characteristics and interaction modes of six major standardized approaches enabling direct cytosolic access of macromolecular cargoes without endosomal ...

Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...

Researchers have developed new real-time microscopy technology and successfully observed the behavior of 'motor proteins', which may hold the key to unraveling the efficient material transport ...

“I think there’s not a lot of information as to what the process is for individuals who have questions about that,” explains Kerry Rogers, MD. Rogers walks through the therapy step by step, from ...

Autologous CD19 CAR T products (tisagenlecleucel, axicabtagene ciloleucel, lisocabtagene maraleucel, brexucabtagene autoleucel) show high response rates across ALL and NHL, now including second-line ...